C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 243/38 (2006.01) A61K 31/551 (2006.01) A61P 3/00 (2006.01)
Patent
CA 2521337
The present invention relates to novel benzodiazepine compounds exhibiting RXR- antagonist efficacy, for delaying progression of, preventing or treating a condition or disease being associated with RXR-antagonism, in particular selected from diabetes, complication of diabetes such as retinopathy, nephropathy, neuropathy, and hyperlipidemia, obesity, dyslipidemia, and osteoporosis.
L'invention concerne de nouveaux composés de benzodiazépine efficaces en tant qu'antagonistes du RXR. Ces composés servent à ralentir la progression d'un trouble ou d'une maladie, à prévenir ou à traiter un trouble ou une maladie associés à l'antagonisme du RXR, notamment un maladie comme le diabète, le diabète de type 2, les complications dues au diabète telles que la rétinopathie, la néphropathie, la neuropathie et l'hyperlipidémie, l'obésité, la dyslipidémie et l'ostéoporose.
Kimura Masaaki
Kishida Masashi
Konishi Kazuhide
Mitani Hironobu
Sakaki Junichi
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
11-phenyl-dibenzodiazepine derivatives as rxr-antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 11-phenyl-dibenzodiazepine derivatives as rxr-antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 11-phenyl-dibenzodiazepine derivatives as rxr-antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1676412